| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.23 | 8e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |